[Selective effect of nispex in inhibiting human cancer cell proliferation and inducing cell apoptosis]

Yi-Jun Xiao1, Yuan-Zhong Chen, Bing-Hua Chen

  • 1Fujian Institute of Hematology, Union Hospital, Fujian Medical University, Fuzhou.

Abstract

Insights

Nispex, a total flavonoids extract from Scurrula parasitic L., selectively inhibits human cancer cell proliferation and induces apoptosis. This natural plant extract shows promising anticancer properties with minimal impact on non-tumor cells.

Area of Science:

  • Phytochemistry
  • Cell Biology
  • Pharmacology

Context:

  • Scurrula parasitic L. is a plant with traditional medicinal uses.
  • Natural products are a rich source of potential anticancer agents.
  • Understanding selective cytotoxicity is crucial for developing targeted cancer therapies.

Purpose:

  • To evaluate the in vitro anticancer effects of Nispex, a total flavonoids extract from Scurrula parasitic L.
  • To determine the selectivity of Nispex against human cancer cells versus non-tumor cells.
  • To investigate the mechanisms of cell death induced by Nispex, including apoptosis.

Summary:

  • Nispex demonstrated significant inhibition of human cancer cell proliferation and induced apoptosis across various cancer cell lines, particularly in rapidly dividing cells.
  • The extract exhibited minimal inhibitory effects on human non-tumor cells, indicating good selectivity.
  • Nispex showed no significant effect on murine cancer cells within the tested concentration range.

Impact:

  • Nispex exhibits selective in vitro anticancer activity, targeting human cancer cells while sparing normal human cells.
  • This study highlights the potential of Nispex as a lead compound for developing novel, targeted cancer therapeutics.
  • The findings support the ethnobotanical use of Scurrula parasitic L. and warrant further investigation into its bioactive components.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...